Dotagraf 10 (Gadoteric acid Ampoules) 2.793g/10ml

Dotagraf 10 contains gadoteric acid, a contrast agent used in MRI scans to enhance image clarity. This 2.793g/10ml ampoule form is designed for intravenous administration. Ideal for radiology departments seeking reliable contrast imaging solutions. Store between 2-8°C to maintain potency.

Strength

2.793g/10ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Berlis AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dotagraf 10 is primarily used as a contrast agent in magnetic resonance imaging (MRI) to improve the visibility of internal body structures. It helps radiologists detect abnormalities in soft tissues, blood vessels, and organs during diagnostic procedures. This gadoteric acid formulation is particularly useful for enhancing images in brain, spine, and musculoskeletal scans. Patients often ask, 'what is Dotagraf 10 used for' in clinical settings.

Side Effects

After administration, Dotagraf 10 works by temporarily altering the magnetic properties of tissues, making them appear brighter on MRI scans. This enhancement allows for clearer differentiation between healthy and abnormal tissues. Some patients may experience mild warmth or flushing during injection, which is generally temporary. Headaches or nausea can occur but are usually short-lived.

Precautions & Warnings

Dotagraf 10 should only be handled by healthcare professionals trained in MRI contrast administration. Patients with severe kidney disease or a history of allergic reactions to gadolinium-based contrast agents should avoid this product. Ensure proper storage at 2-8°C and inspect the ampoule for damage or discoloration before use. Discard any unused portion after opening.

Avoid Interactions

Dotagraf 10 may interact with medications that affect kidney function, such as certain diuretics or nephrotoxic drugs. Patients taking metformin should consult their doctor, as contrast agents can temporarily impair kidney function. Alcohol and other sedatives may increase the risk of side effects like dizziness. Always disclose all medications to your healthcare provider before receiving Dotagraf 10.

Frequently Asked Questions

Dotagraf 10 is administered intravenously by a healthcare professional during an MRI procedure.

Common side effects may include mild warmth, flushing, headache, or nausea, which typically resolve quickly.

Patients with severe kidney disease should avoid Dotagraf 10 unless approved by a doctor due to potential risks.

The safety of Dotagraf 10 during pregnancy has not been established; consult your healthcare provider.

Store Dotagraf 10 between 2-8°C and protect it from light until ready for use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.